JH
Insider
Jon Halbert
DirectorJon Halbert (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales, 1 filed past the two-business-day deadline), most often in Caris Life Sciences, Inc. (CAI). Across 1 priced purchase filing, the average 21-session return was +19.2% from execution and +36.8% from disclosure (delay-adjusted; derived). The largest single filing was $990K of CAI (68,000 sh × $14.56, as filed), executed May 15.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+19.2%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+36.8%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells · 1 late
Median delay
59d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$990K
shares × price, as filed
Last traded
May 15
Filed Jul 13
Median ADV $49.4M across their filed names
Open performance→Volume by month
Buys $990K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
CAIRecent filings
CAIPURCHASE
Caris Life Sciences, Inc.
View filing →
$990K68,000 sh × $14.56
Exec May 15
Filed Jul 13 · 7:06 AM ET †